Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
[1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-ジフルオロフェニル)-シクロプロピルアミノ]-5-(プロピルチオ)-3H-1,2,3-トリアゾロ[4,5-d]ピリミジン-3-イル]-5-(2-ヒドロキシエトキシ)シクロペンタン-1,2-ジオールおよびその中間体の製造方法
Document Type and Number:
Japanese Patent JP2012502024
Kind Code:
A
Abstract:
The present invention is directed to a process for preparing [1S-[1alpha,2alpha,3beta(1S*,2R*),5beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to intermediates useful in the process.

Inventors:
Aufden Bratten, Ronnie
Borin, Martin Hans
Helstroom, Helena
Johansson, Peter Wee
Larsson, Wolf Geh
Lennagel, Michaela
Weiss, Andreas
Application Number:
JP2011526012A
Publication Date:
January 26, 2012
Filing Date:
September 08, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AstraZeneca Activrag
International Classes:
C07H19/23; C07H9/02; C07H17/02
Domestic Patent References:
JP2002503663A2002-02-05
JP2003535093A2003-11-25
JP2002503663A2002-02-05
Attorney, Agent or Firm:
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Akiko Nakahama



 
Previous Patent: 縮合複素環化合物

Next Patent: 二酸化炭素の還元